---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-002127"
form_type: "8-K"
ticker: "LCTX"
cik: "0000876343"
company_name: "Lineage Cell Therapeutics, Inc."
filed_at: "2023-01-23T23:59:59+00:00"
generated_at: "2026-06-20T12:09:24.973931+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Lineage Cell Therapeutics furnishes corporate investor presentation dated Jan 23, 2023

## Summary
- Presentation covers Lineage's product candidates and recent business developments.
- Filed under Regulation FD; presentation furnished, not filed.
- No specific financial or operational updates disclosed in available text.

## SEC filing metadata
- accession: 0001493152-23-002127
- form_type: 8-K
- ticker: LCTX
- cik: 0000876343
- company_name: Lineage Cell Therapeutics, Inc.
- filed_at: 2023-01-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/876343/000149315223002127/0001493152-23-002127-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/876343/000149315223002127/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-002127
- JSON: https://secwatch.observer/filing/0001493152-23-002127.json
- Plain text: https://secwatch.observer/filing/0001493152-23-002127.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.